Continuing Education credits for the Symposium on Clinical Interventional Oncology (CIO) are provided by the North American Center for Continuing Medical Education, LLC (NACCME).
The live/live broadcast activity will take place from October 22 – 24, 2021. Recorded sessions will be available on-demand for credit until January 24, 2022.
Additional credit applications and approvals are pending. This page will be updated upon approval.
Please contact email@example.com for any specific requests or more information.
The Symposium on Clinical Interventional Oncology (CIO) is designed for interventional radiologists, surgeons, oncologists, and other healthcare professionals involved in the treatment of cancer or looking to expand into this arena.
After attending the Symposium on Clinical Interventional Oncology (CIO), participants should be able to:
Describe catheter-based procedures to treat solid tumors, using the latest techniques and technologies
Assess the most appropriate therapeutic agent in catheter-directed therapy for hepatic malignancies
Demonstrate appropriate decision-making skills and techniques in ablation involving tumors of the kidney, bone, liver, and lung
Apply appropriate technique and biomarker testing of percutaneous biopsies
Determine the most appropriate imaging modalities during assessment, treatment, and follow-up of patients
Analyze the evidence behind the various modalities utilized in interventional oncology
In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Live/ Internet Live
NACCME designates this live/internet live activity for a maximum of 18 AMA PRA Category 1 Credits™.
NACCME designates this internet enduring activity for a maximum of 18 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This live/internet live activity is designated for 18 AAPA Category 1 credits.
NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 18 AAPA Category 1 credits.
PAs should only claim credit commensurate with the extent of their participation.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Live/ Internet Live
This continuing nursing education live/internet live activity awards 18 contact hours.
Provider approved by the California Board of Registered Nursing, Provider Number 13255 for 18 contact hours.
This continuing nursing education internet enduring activity awards a maximum of 18 contact hours for this enduring activity. Provider approved by the California Board of Registered Nursing, Provider #13255 for 18 contact hours.
Radiologic Techs (ARRT Credits)
CIO, taking place Friday, October 22–Sunday, October 24, 2021 has been submitted for approval of ARRT Cat A+ Continuing Education credits by the Association of Vascular & Interventional Radiographers (AVIR).
AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism (RCEEM).
UEMS/EACCME CME Credit Recognition
The American Medical Association (AMA) has an agreement of mutual recognition of CME credit with the UEMS. Under the terms of this agreement, the European Accreditation Council for Continuing Medical Education (EACCME), the accrediting arm of the UEMS, will convert CME credit for live activities certified by the AMA.
Disclosure of Relevant Financial Relationships
NACCME, LLC is an independent provider of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, NACCME is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real conflicts of interest between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- any investigational, off-label, or non-FDA approved content or discussion
NACCME has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified conflicts of interest, and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by NACCME, LLC may contact Samantha Conforti, Manager, Accreditation and Compliance, by phone at 609.630.6208, by email at firstname.lastname@example.org, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Conforti will review the grievance and respond within 30 days of receiving the complaint. If the participant is unsatisfied with the response, an appeal to the Associate Director, Accreditation & Compliance, Greaton Sellers, can be requested for a second level of review. Mr. Sellers can be contacted via phone at 609.371.1137 x4111, by email at email@example.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 770.751.7332/609.371.1137.
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your non-public personal information.
Copyright © 2021 by North American Center for Continuing Medical Education, LLC. All rights reserved.
The following companies have provided commercial support for this activity:
Genentech, Boston Scientific Corporation, Sirtex, BD, Guerbet, Argon Medical Devices, and Obsidio.